12 min read
I’ve worked through over 50 fundraises in the past five years. Same issue keeps showing up: founders have no clue what their company’s actually worth. Some anchor to a spreadsheet their mate’s cousin built. Others just take whatever number the VC tosses out. Neither works.
Valuation isn’t magic. It’s formulaic-apply the right frameworks and you get a real number. What’s your company worth today? What about in five years? The Indian startup world is finally taking this seriously.
Projected Indian startup market value by 2030
Startups funded in India in 2025
Median pre-Series A valuation
$38.4 billion hit the Indian VC market in 2024. That’s cash moving, deals happening, and founders getting caught without a clue about what their companies are worth.
Five methods, top to bottom. Use the right one at the right time. Skip the pitfalls.
Why Startup Valuation Matters: Beyond the Number
Three things hang on this. Nothing else. Just these three.
It’s your use. Understand valuation and you own the negotiation. Skip it and anyone can walk in and dictate.
The Five Startup Valuation Methods: A Comparative Framework
Pick based on where you are. Stage matters. Revenue matters. Data matters.
| Method | Best For | Key Input | Difficulty | Pre-Revenue? | Speed |
|---|---|---|---|---|---|
| Berkus Method | Early-stage (pre-revenue to โน1-2 Cr ARR) | Founder quality, idea, team | Low | Yes | 1-2 hours |
| Scorecard Method | Pre-seed to Seed (pre-revenue to โน2-3 Cr ARR) | Stage-adjusted market comps | Low-Medium | Yes | 2-4 hours |
| VC Method | Venture-scale (Series A+) | Target exit value, target IRR | Medium | No (requires unit economics path) | 3-6 hours |
| Comparable Company Analysis | Revenue-generating (โน1+ Cr ARR) | Revenue multiples, growth rates | Medium-High | No | 4-8 hours |
| Discounted Cash Flow (DCF) | Mature or near-exit (โน5+ Cr ARR with clear path) | 10-year cash flows, discount rate | High | No | 8-20 hours |
Maturity = more data, better answers. No revenue yet? Berkus or Scorecard. โน5+ Cr ARR and Series A knocking? DCF works now.
Method 1: The Berkus Method (Pre-Revenue Startups)
Berkus is straightforward-five risk buckets, โน40 L each, max out at โน2 Cr. Pre-revenue only.
The five components:
Worked Example: You’re a pre-revenue SaaS startup. You’ve got:
- A validated problem (survey of 100+ SMEs confirmed pain). โน40 L.
- A working MVP (5 pilot customers, 2-week onboarding). โน40 L.
- Founder is ex-director at a โน500 Cr SaaS scale-up, with a technical co-founder. โน40 L.
- No strategic partnerships yet. โน0.
- Beta users active but no revenue. โน0.
Berkus Valuation: โน120 Lakhs (โน1.2 Cr).
For a โน50 L pre-seed round, you’d be offering 41.7% dilution. Not bad for capital and validation.
When: Pre-revenue, early-stage only. Fast. Investors get it.
Why: No guessing. Each box is de-risking you. Every โน40 L is real progress.
Method 2: The Scorecard Method (Seed Stage)
Scorecard is Berkus with a market check. Adjust your score against peers in your space, your stage, your region.
The formula:
Worked Example: You’re a B2B fintech startup seeking Seed funding. Comparable Seed-stage fintech startups in India (based on Tracxn 2025 data) have a median post-money valuation of โน8 Cr.
Now you score yourself against peers on a 0.5x to 1.5x scale across five criteria:
- Team: Your founder is from IIT + worked at Google. Peers are mixed. You score 1.2x.
- Prototype: You have working MVP. Most peers do too. 1.0x.
- Market Size: โน50,000 Cr TAM in B2B lending. Strong. 1.1x.
- Strategic Partnerships: You’ve got a pilot with an NBFC. Rare. 1.3x.
- Product Stage: โน25 L MRR, 12% month-on-month growth. 1.15x.
Average: (1.2 + 1.0 + 1.1 + 1.3 + 1.15) / 5 = 1.15x
Scorecard Valuation: โน8 Cr ร 1.15 = โน9.2 Cr post-money.
For a โน2 Cr raise, pre-money = โน7.2 Cr. That’s a 21.7% dilution-reasonable for Seed.
When: Seed stage, up to โน3 Cr revenue. Works because you’re benchmarking against your peers. Forces you to do competitive intel anyway.
Why: VCs use it. You walk in with Tracxn data backing you. That’s math, not opinion.
Method 3: The VC Method (Venture-Scale Companies)
This is VC math. Work backwards from exit-apply their return target and you hit today’s valuation.
The formula:
Worked Example: You’re Series A-ready with โน2 Cr ARR, 120% net retention, and clear path to โน50 Cr+ ARR. You’re seeking a โน15 Cr Series A.
Assumptions:
- Exit Value (10-year projection): โน1,000 Cr (SaaS company trading at 8-10x revenue). Reasonable for B2B SaaS with strong unit economics.
- Target Return Multiple: 15x (mid-range for Series A venture). Investors need this to generate headline returns across the portfolio.
- Current round: โน15 Cr Series A.
- Planned future capital: โน30 Cr (Series B) + โน20 Cr (Series C). Total dilution: โน65 Cr.
Required pre-money valuation: (โน1,000 Cr / 15) – โน65 Cr = โน66.67 Cr – โน65 Cr = โน1.67 Cr pre-money.
For a โน15 Cr Series A, post-money = โน16.67 Cr. You’re offering 90% dilution to get to 15x exit math. That’s tight-typical for Series A at your stage.
When: Series A onward. Unit economics proven. You need a โน50+ Cr path to exist. Investors do this math in their heads-you do it out loud.
Why: No guessing. Just maths. What’s the exit? What’s the return? Where’s today’s price?
Pro tip: If your VC Method valuation feels too low, your exit assumptions are weak or your return multiple is unrealistic. That’s not a valuation problem-it’s a growth problem. Fix it before fundraising. [Read: Understanding Startup Funding Stages: Pre-Seed to Series C in India]
Method 4: Comparable Company Analysis (Revenue-Generating Startups)
Pull comparable sales. Find what similar companies sold for. Extract the multiple. Apply it to your revenue.
The formula:
Worked Example: You’re a B2B logistics SaaS company with โน8 Cr ARR and 45% growth. You pull comps:
| Company | ARR | Growth % | Valuation/Market Cap | EV/Revenue Multiple |
|---|---|---|---|---|
| Blackbuck (acquired 2020) | โน100+ Cr | 40%+ | $200 M (โน1,600 Cr) | ~16x |
| Shiprocket (unicorn, 2023) | โน150+ Cr | 50%+ | $2.1 B (โน17,500 Cr) | ~117x |
| Ezyride (Series B, 2024) | โน12 Cr | 80% | โน60 Cr (implied pre-Series B) | ~5x |
| Median (ex-Shiprocket outlier) | – | – | – | ~10.5x |
Your company: โน8 Cr ARR, 45% growth. You’re smaller and slower-growing than Blackbuck, but more mature than Ezyride. Reasonable adjustment: 6-8x revenue multiple.
CCA Valuation: โน8 Cr ร 7x (midpoint) = โน56 Cr.
That’s a realistic Series A valuation for a high-quality logistics SaaS at your stage.
When: Series A+, when you’ve got revenue (โน1 Cr+) and real traction. Transparent. Show comps, show multiple.
Why: The market priced similar companies already. You’re borrowing their credibility.
Important caveat: Comp selection matters enormously. Include weak comps and you’ll undersell yourself. Include only strong comps and you’ll oversell. You need at least 4-6 legitimate comparables for the analysis to hold water.
Method 5: Discounted Cash Flow (DCF) Valuation
DCF is the heavyweight. Project 10 years forward. Discount back. You’ve got enterprise value. It’s intricate but airtight.
The formula:
Worked Example: You’re a โน5 Cr ARR B2B SaaS company with 50% growth and a path to โน100 Cr ARR by Year 10. You project:
- Years 1-3: 50% growth, 20% EBITDA margin
- Years 4-7: 35% growth, 30% EBITDA margin
- Years 8-10: 15% growth, 35% EBITDA margin
- Tax rate: 25% (India corporate tax)
- Discount rate (WACC): 14% (appropriate for venture-backed SaaS)
Projected cash flows:
| Year | Revenue (โน Cr) | EBITDA Margin % | EBITDA (โน Cr) | Discount Factor | PV of CF (โน Cr) |
|---|---|---|---|---|---|
| 1 | 7.5 | 20% | 1.50 | 0.877 | 1.31 |
| 2 | 11.3 | 20% | 2.26 | 0.769 | 1.74 |
| 3 | 17.0 | 20% | 3.40 | 0.675 | 2.29 |
| 4 | 22.9 | 30% | 6.87 | 0.592 | 4.07 |
| 5-7 (avg) | 45.0 (avg) | 30% | 13.5 (avg) | 0.467 (avg) | 18.96 |
| 8-10 (avg) | 72.0 (avg) | 35% | 25.2 (avg) | 0.312 (avg) | 23.61 |
| Sum of Present Values (Years 1-10): | โน51.98 Cr |
Terminal Value (Year 10 onwards, 3% perpetual growth): โน100 Cr revenue ร 35% EBITDA ร (1.03 / (0.14 – 0.03)) = โน107.5 Cr. Present value = โน107.5 Cr ร 0.270 = โน29.03 Cr.
Enterprise Value = โน51.98 Cr + โน29.03 Cr = โน80.01 Cr.
โน80 Cr. Solid for Series B. But shift growth five points either way and you’re at โน55 Cr or โน110 Cr. Assumptions kill this thing.
When: Series B-C, with 2-3 years of actual data and a credible 10-year model. Investors scrutinise assumptions hard. Sensitivity analysis isn’t optional.
Why: Every rupee is tied to an assumption you can defend. Which is also the trap-bad assumptions wreck it. Trash in, trash out.
Pro tip: Use DCF not to set valuation, but to understand valuation sensitivity. Build your model, run it, and ask: “What growth rate am I implicitly assuming at a โน75 Cr valuation?” If it’s unrealistic, your valuation is too high. [Read: Financial Modelling for Startups in India: A Practical Guide]
Method Comparison: Which Method When?
Never use one. Run all of them. Triangulate.
| Your Stage | Primary Method | Secondary Method | Why |
|---|---|---|---|
| Pre-revenue to โน50 L ARR | Berkus | Scorecard | No revenue to benchmark. You’re pricing risk reduction and team quality. |
| โน50 L-โน2 Cr ARR | Scorecard | VC Method (forward-looking) | Revenue exists but too early for hard comps. Scorecard is peer-relative; VC Method anchors to exit. |
| โน2-โน5 Cr ARR | VC Method or CCA | DCF (sensitivity only) | Revenue is sizeable. CCA works if comps exist. VC Method bridges Seed and Series A. |
| โน5+ Cr ARR, Series B+ | DCF | CCA | You have track record. DCF is most rigorous. CCA provides market reality check. |
The pattern: start with founder-centric methods (Berkus, Scorecard), graduate to market-centric methods (CCA, VC Method), and finish with cash-flow-centric methods (DCF) once you have real financials.
Five Common Startup Valuation Mistakes (And How to Avoid Them)
Same mistakes over and over. Here’s what to avoid:
Valuation Tools & Resources for Indian Founders
Don’t build from zero. Tools exist.
- Tracxn: Real data on Indian startup valuations, comparable rounds, investor profiles. [tracxn.com]
- Inc42: News, funding reports, and annual valuation benchmarks. [inc42.com]
- Carta: Equity management and valuation modeling (used by 500+ Indian startups). [carta.com]
- Pulley: Cap table management with valuation scenario modeling. [pulley.com]
- Excel + financial modeling frameworks: If you’re comfortable with finance, build your own using the DCF and CCA frameworks above. Most serious founders do.
Key Takeaways
Remember This
- Startup valuation is not guesswork. It’s a disciplined application of five proven methods, each suited to different stages and data availability.
- Berkus and Scorecard are your pre-revenue and Seed tools. Rapid, founder-friendly, peer-relative.
- VC Method and CCA are your Series A tools. Investor-aligned and market-aware.
- DCF is your Series B+ tool. Rigorous but assumption-dependent.
- Use multiple methods and triangulate. A 20-30% range is healthy; false precision is a red flag.
- Valuation is not price. Know your worth, but negotiate flexibly.
- Common mistakes (single method, ignoring dilution, weak assumptions, outdated comps) cost founders millions in ownership. Avoid them.
- The Indian startup market is maturing. Founders who understand valuation methodology negotiate better deals and build more sustainable cap tables.
Frequently Asked Questions
Q: What’s the difference between pre-money and post-money valuation?
Pre-money is what your company is worth before fresh capital comes in. Post-money is the value after. If you’re valued at โน100 Cr pre-money and raise โน20 Cr, post-money is โน120 Cr. Post-money valuation determines your dilution: you’re offering โน20 Cr / โน120 Cr = 16.7% ownership to the investor. Always know your post-money valuation-it tells you what you’re giving away.
Q: Should I use the valuation a previous investor suggested?
No. A previous investor’s suggested valuation reflects their desired return and risk tolerance, not your company’s intrinsic value. Use it as a data point, but run your own analysis. I’ve seen founders accept a โน30 Cr “valuation” from a micro-VC and then be shock-shocked when Series A investors say โน25 Cr is fair. Your valuation is your number; you own it.
Q: Can I use revenue multiples from public companies?
Cautiously. Publicly traded companies trade at different multiples than private startups (lower risk, liquidity premium). If a public SaaS company trades at 8x revenue, a private one in the same market trades at 5-7x. The gap reflects illiquidity, founder concentration, and execution risk. If you use public company multiples, apply a 20-30% discount for stage and risk. Better: use comps from recent Series A-C rounds in your vertical (Tracxn, Inc42 have this data).
Q: How often should I revalue my company?
Annually if you’re raising capital. Quarterly if major milestones shift (acquisition, major partnership, significant revenue miss). Don’t revalue after every small win-it looks desperate. But once a year or before a fundraise, run fresh numbers. Markets move, comps change, and your business data improves. Your valuation should reflect all of it.
Q: What if my DCF valuation and Scorecard valuation are wildly different?
It means one of three things: (1) Your DCF assumptions are unrealistic (most likely), (2) Your comps are wrong, or (3) The market fundamentally disagrees with your long-term thesis. Dig in. Ask yourself: “What growth rate does the Scorecard valuation imply over 10 years?” If it’s 5% and you’re projecting 25%, your assumptions are out of sync with market reality. Either fix your model or reconsider your growth thesis.
The Bottom Line
Own the math and you own the room. Walk in, explain โน75 Cr instead of โน50 or โน100, and you’re credible. Not arguing. Maths.
Berkus if pre-revenue. Scorecard for Seed. VC Method for Series A. DCF after 2-3 years of real numbers. Run all three, understand the assumptions, triangulate. That band is your negotiation floor.
These five methods, those five mistakes-that’s the whole thing. Next fundraise, you walk in with clarity. Not hope. Not desperation. Numbers.
Sources & References
- EY-IVCA, PE/VC Trendbook, 2025
- Dave Berkus, Berkus Method, 2024
- Bain & Company, India Venture Report, 2025
- NASSCOM, India Tech Industry Report, 2025
- Tracxn, India Venture Data, 2025
- Inc42, Indian Startup Funding Report, 2025
Topics: